Stryker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. 

CEO
Kevin A. Lobo
CEOKevin A. Lobo
Employees
53,000
Employees53,000
Headquarters
Portage, Michigan
HeadquartersPortage, Michigan
Founded
1941
Founded1941
Employees
53,000
Employees53,000

SYK Key Statistics

Market cap
141.05B
Market cap141.05B
Price-Earnings ratio
48.11
Price-Earnings ratio48.11
Dividend yield
0.93%
Dividend yield0.93%
Average volume
1.43M
Average volume1.43M
High today
$370.88
High today$370.88
Low today
$364.11
Low today$364.11
Open price
$364.90
Open price$364.90
Volume
840.99K
Volume840.99K
52 Week high
$406.19
52 Week high$406.19
52 Week low
$329.16
52 Week low$329.16

Stock Snapshot

As of today, Stryker(SYK) shares are valued at $368.83. The company's market cap stands at 141.05B, with a P/E ratio of 48.11 and a dividend yield of 92.8%.

During the trading session on 2026-01-08, Stryker(SYK) shares reached a daily high of $370.88 and a low of $364.11. At a current price of $368.83, the stock is +1.3% higher than the low and still -0.6% under the high.

Trading volume for Stryker(SYK) stock has reached 840.99K, versus its average volume of 1.43M.

The stock's 52-week range extends from a low of $329.16 to a high of $406.19.

The stock's 52-week range extends from a low of $329.16 to a high of $406.19.

SYK News

Simply Wall St 1d
How Raymond James’ Upgrade and 2025 Earnings Date Could Shape Stryker’s Investment Narrative

Stryker recently announced it will report its fourth-quarter and full-year 2025 results on January 29, 2026, alongside a webcast discussion of the figures. Thi...

How Raymond James’ Upgrade and 2025 Earnings Date Could Shape Stryker’s Investment Narrative
Nasdaq 2d
Why Stryker Stock Popped Today

Key Points Raymond James analyst Jayson Bedford upgrades Stryker stock to outperform today. The medical devices stock has grown sales at 10% or better for fiv...

Why Stryker Stock Popped Today
TipRanks 2d
Stryker upgraded to Outperform from Market Perform at Raymond James

Raymond James upgraded Stryker (SYK) to Outperform from Market Perform with a $418 price target The company has been one of the “highest quality compounders” in...

Analyst ratings

81%

of 32 ratings
Buy
81.3%
Hold
15.6%
Sell
3.1%

More SYK News

Simply Wall St 2d
Stryker's investors will be pleased with their notable 54% return over the last five years

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the mark...

Stryker's investors will be pleased with their notable 54% return over the last five years
TipRanks 3d
Stryker price target lowered to $390 from $405 at Evercore ISI

Evercore ISI lowered the firm’s price target on Stryker (SYK) to $390 from $405 and keeps an Outperform rating on the shares. Recovering end markets and sector...

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.